Tysabri and Urinary bladder sarcoma - a phase IV clinical study of FDA data
Urinary bladder sarcoma is reported only by a few people who take Tysabri.
The phase IV clinical study analyzes which people take Tysabri and have Urinary bladder sarcoma. It is created by eHealthMe based on reports of 210,327 people who have side effects while taking Tysabri from the FDA, and is updated regularly.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
210,327 people reported to have side effects when taking Tysabri.
Among them, 2 people (0.0%) have Urinary bladder sarcoma.
What is Tysabri?
Tysabri has active ingredients of natalizumab. It is often used in multiple sclerosis. eHealthMe is studying from 210,824 Tysabri users for its effectiveness, alternative drugs and more.
What is Urinary bladder sarcoma?
Urinary bladder sarcoma (urinary bladder cancer) is found to be associated with 16 drugs and 5 conditions by eHealthMe.
Number of Tysabri and Urinary bladder sarcoma reports submitted per year:
Time on Tysabri when people have Urinary bladder sarcoma *:
- < 1 month: 0.0 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 100 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
Gender of people who have Urinary bladder sarcoma when taking Tysabri *:
- female: 100 %
- male: 0.0 %
Age of people who have Urinary bladder sarcoma when taking Tysabri *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 0.0 %
- 20-29: 0.0 %
- 30-39: 0.0 %
- 40-49: 0.0 %
- 50-59: 0.0 %
- 60+: 100 %
Common side effects people have besides Urinary bladder sarcoma *:
- Urinary Tract Infection: 2 people, 100.00%
- Pollakiuria (abnormally frequent passage of relatively small quantities or urine): 2 people, 100.00%
- Ovarian Cancer (cancer of ovary): 2 people, 100.00%
- Intestinal Mass: 2 people, 100.00%
- Gastric Cancer (stomach cancer): 2 people, 100.00%
- Colon Cancer: 2 people, 100.00%
- Blood Urine Present: 2 people, 100.00%
- Neoplasm Malignant (cancer tumour): 1 person, 50.00%
- Death: 1 person, 50.00%
* Approximation only. Some reports may have incomplete information.
Do you take Tysabri and have Urinary bladder sarcoma?Check whether Urinary bladder sarcoma is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
How severe was Urinary bladder sarcoma and when was it recovered:
Expand to all the drugs that have ingredients of natalizumab:
Alternative drugs to, pros and cons of Tysabri:
- Tysabri (210,824 reports)
Common Tysabri side effects:
- Fatigue (feeling of tiredness): 23,185 reports
- Weakness: 14,800 reports
- Headache (pain in head): 11,871 reports
- Memory loss: 11,095 reports
- Multiple sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 11,021 reports
- Urinary tract infection: 9,886 reports
Browse all side effects of Tysabri:a b c d e f g h i j k l m n o p q r s t u v w x y z
Urinary bladder sarcoma treatments and more:
- Urinary bladder sarcoma (26 reports)
COVID vaccines that are related to Urinary bladder sarcoma:
- Urinary bladder sarcoma in Moderna COVID Vaccine
- Urinary bladder sarcoma in Pfizer BioNTech Covid Vaccine
- Urinary bladder sarcoma in Johnson and Johnson Covid Vaccine
All the drugs that are associated with Urinary bladder sarcoma:
- Urinary bladder sarcoma (16 drugs)
All the conditions that are associated with Urinary bladder sarcoma:
- Urinary bladder sarcoma (5 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on natalizumab (the active ingredients of Tysabri) and Tysabri (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Retroperitoneal Neoplasm and Thrombocytopenia - 2 seconds ago
- Chloramphenicol and Drowsiness - 5 seconds ago
- Cytoxan and Dermoid Cyst - 15 seconds ago
- Cogentin and Hepatitis C - 16 seconds ago
- Botox and Eosinophil Count Decreased - 23 seconds ago
- Magnesium and Common Peroneal Nerve Dysfunction - 27 seconds ago
- Myrbetriq and Hyperparathyroidism Secondary - 47 seconds ago
- Isovue-128 and Florinef drug interaction - a minute ago
- Heparin Sodium and Temporomandibular Joint Syndrome - a minute ago
- Acetaminophen vs. Bupropion Hydrochloride - a minute ago